Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BriaCell Therapeutics Corp. - Warrant expiring 2026 (NQ:BCTXW)

0.0060 +0.0002 (+3.45%)
Streaming Delayed Price Updated: 9:31 AM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,553
Open 0.0060
Bid (Size) 0.0060 (71,400)
Ask (Size) 0.0070 (2,000)
Prev. Close 0.0058
Today's Range 0.0060 - 0.0060
52wk Range 0.0017 - 0.2500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Wondering what's happening in today's pre-market session? ↗
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
Thursday's session: gap up and gap down stocks ↗
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill

Performance

YTD
-89.6%
-89.6%
1 Month
-76.9%
-76.9%
3 Month
-87.0%
-87.0%
6 Month
-76.3%
-76.3%
1 Year
-95.3%
-95.3%

More News

Read More
News headline image
Discover the top movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers ↗
Via Talk Markets
News headline image
BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer ↗
Via Talk Markets
News headline image
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Via News Direct
Topics Death
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Via TheNewswire.com
Topics Death
News headline image
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients ↗
Via Benzinga
News headline image
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients ↗
Via Benzinga
News headline image
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
From ImmunoPrecise Antibodies
Via Business Wire
News headline image
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
From Stock News Now
Via AccessWire
Topics Cannabis

Frequently Asked Questions

Is BriaCell Therapeutics Corp. - Warrant expiring 2026 publicly traded?
Yes, BriaCell Therapeutics Corp. - Warrant expiring 2026 is publicly traded.
What exchange does BriaCell Therapeutics Corp. - Warrant expiring 2026 trade on?
BriaCell Therapeutics Corp. - Warrant expiring 2026 trades on the Nasdaq Stock Market
What is the ticker symbol for BriaCell Therapeutics Corp. - Warrant expiring 2026?
The ticker symbol for BriaCell Therapeutics Corp. - Warrant expiring 2026 is BCTXW on the Nasdaq Stock Market
What is the current price of BriaCell Therapeutics Corp. - Warrant expiring 2026?
The current price of BriaCell Therapeutics Corp. - Warrant expiring 2026 is 0.0060
When was BriaCell Therapeutics Corp. - Warrant expiring 2026 last traded?
The last trade of BriaCell Therapeutics Corp. - Warrant expiring 2026 was at 02/19/26 09:31 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.